Evidence map›Paper›PMID 28515356›Full record

ArticleJCI insight2017

Licensing delineates helper and effector NK cell subsets during viral infection.

Anthony E Zamora, Ethan G Aguilar, Can M Sungur, Lam T Khuat, Cordelia Dunai, G Raymond Lochhead, Juan Du, Claire Pomeroy, Bruce R Blazar, Dan L Longo and 3 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Immune surveillance of cytomegalovirus in tissues.Cellular & molecular immunology · 2024
    Review
  2. Human natural killer cells: Form, function, and development.The Journal of allergy and clinical immunology · 2023
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. NK cells for cancer immunotherapy.Nature reviews. Drug discovery · 2020
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. NK and NKT-Like Cells in Patients with Recurrent Furunculosis.Archivum immunologiae et therapiae experimentalis · 2018
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Anthony E ZamoraDepartment of Dermatology.
Ethan G AguilarDepartment of Dermatology.
Can M SungurDepartment of Dermatology.
Lam T KhuatDepartment of Dermatology.
Cordelia DunaiDepartment of Dermatology.
G Raymond LochheadDepartment of Internal Medicine, UC Davis School of Medicine, Sacramento, California, USA.
Juan DuDepartment of Medicine, UCSF, San Francisco, California, USA.
Claire PomeroyPresident of Lasker Foundation, Albert and Mary Lasker Foundation, New York City, New York, USA.
Bruce R BlazarMasonic Cancer Center and Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.
Dan L LongoNational Institute on Aging, NIH, Baltimore, Maryland, USA.
Jeffrey M VenstromDepartment of Medicine, UCSF, San Francisco, California, USA.
Nicole BaumgarthCenter for Comparative Medicine, UC Davis, Davis, California, USA.
William J MurphyDepartment of Dermatology.
University of California, Davis · USUniversity of California, San Francisco · USNational Institute on Aging · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Trial Design and Biostatistical Support CoreP01CA065493 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Mark J Osborn · 1995 to 2026
$48.2M
GVL TO REDUCE AML RELAPSE AFTER MURINE ALLOGENEIC BMTR01CA072669 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BLAZAR, BRUCE R · 1997 to 2017
$4.9M
Animal Models of Infectious Diseases Training ProgramT32AI060555 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI MCSORLEY, STEPHEN J · 2004 to 2025
$3.3M
NCI NIH HHS P01 CA065493NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA072669NIAID NIH HHS T32 AI060555
6 · The paper itself

Abstract

Natural killer (NK) cells can be divided into phenotypic subsets based on expression of receptors that bind self-MHC-I molecules, a concept termed licensing or education. Here we show NK cell subsets with different migratory, effector, and immunoregulatory functions in dendritic cell and antigen (ag)-specific CD8+ T cell responses during influenza and murine cytomegalovirus infections. Shortly after infection, unlicensed NK cells localized in draining lymph nodes and produced GM-CSF, which correlated with the expansion and activation of dendritic cells, and resulted in greater and sustained ag-specific T cell responses. In contrast, licensed NK cells preferentially migrated to infected tissues and produced IFN-γ. Importantly, human NK cell subsets exhibited similar phenotypic characteristics. Collectively, our studies demonstrate a critical demarcation between the functions of licensed and unlicensed NK cell subsets, with the former functioning as the classical effector subset and the latter as the stimulator of adaptive immunity helping to prime immune responses.

Indexed as

ImmunologyInflammation

Identifiers

PMID28515356
PMCPMC5436543
OpenAlexW2616594891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.